MedTrace Logo

Safety and User Experience of BP-CBB

NCT07628608 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-18

No results posted yet for this study

Summary

This study is the first-in human study for the food ingredient BP-CBB and aims aims to build on the excellent safety and tolerability observed in the extensive food safety assessment performed for BP-CBB, as well as the consumer experience with using the product, and to set the scene for future human studies documenting the health-benefits of daily supplementation with BP-CBB for diverse populations.

Conditions

  • Safety and Tolerability in Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

BP-CBB

Dietary supplement containing BP-CBB

DIETARY_SUPPLEMENT

Placebo

Receives dietary supplement without BP-CBB

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • Bactolife A/S

    lead INDUSTRY

Principal Investigators

  • Martin Buckley, Professor · Atlantia Clinical Trials

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-16
Primary Completion
2026-12-01
Completion
2026-12-01

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07628608 on ClinicalTrials.gov